Your browser doesn't support javascript.
loading
Pharmacokinetics, safety and tolerability of OBE022, a selective prostaglandin F2α receptor antagonist tocolytic: A first-in-human trial in healthy postmenopausal women.
Pohl, Oliver; Marchand, Line; Gotteland, Jean-Pierre; Coates, Simon; Täubel, Jörg; Lorch, Ulrike.
Afiliação
  • Pohl O; ObsEva SA, Plan-les-Ouates, Switzerland.
  • Marchand L; ObsEva SA, Plan-les-Ouates, Switzerland.
  • Gotteland JP; ObsEva SA, Plan-les-Ouates, Switzerland.
  • Coates S; Richmond Pharmacology Ltd., St George's University of London, London, UK.
  • Täubel J; Richmond Pharmacology Ltd., St George's University of London, London, UK.
  • Lorch U; St George's University of London, Cranmer Terrace, London, UK.
Br J Clin Pharmacol ; 84(8): 1839-1855, 2018 08.
Article em En | MEDLINE | ID: mdl-29708281

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulfonas / Receptores de Prostaglandina / Pró-Fármacos / Tocolíticos / Ésteres / Tiazolidinas / Trabalho de Parto Prematuro Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged / Pregnancy Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulfonas / Receptores de Prostaglandina / Pró-Fármacos / Tocolíticos / Ésteres / Tiazolidinas / Trabalho de Parto Prematuro Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged / Pregnancy Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2018 Tipo de documento: Article